Long-term Outcomes of TNF Inhibitors in Psoriatic Arthritis


British investigators take a long-range view of tumor necrosis factor inhibitors in patients with psoriatic arthritis.

Reference1. Fagerli KM, Kearsley-Fleet L, Watson KD, et al. Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register. RMD Open. 2018;4:e000596. doi:10.1136/rmdopen-2017-000596

Related Videos
© 2023 MJH Life Sciences

All rights reserved.